Taking action to ease suffering: Advancing cancer pain control as a health care priority

CA Cancer Journal for Clinicians

Volumn 59, Issue 5, 2009, Pages 285-289

  Brawley, Otis W ^a   Smith, Daniel E ^b   Kirch, Rebecca A ^b  

^a AMERICAN CANCER SOCIETY   (United States)

^b AMERICAN CHEMICAL SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ANALGESIA; CANCER PAIN; CANCER PATIENT; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEALTH CARE DISPARITY; HEALTH CARE PERSONNEL; HUMAN; HUMAN DIGNITY; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIOECONOMICS;

HEALTH PLANNING; HEALTH RESOURCES; HUMANS; NEOPLASMS; PAIN; STRESS, PSYCHOLOGICAL;

EID: 70349208953     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.20030     Document Type: Editorial

References (30)

1. Van den Beuken-van Everdingen MH, deRijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18:1437-1449.
2. Green CR, Montague L, Hart-Johnson MS. Consistent and breakthrough pain in diverse advanced cancer patients: a longitudinal examination. J Pain Symptom Manage. 2009;37;831-847.
3. Green CR, Anderson KO, Baker TA, et al. The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med. 2003;4:277-294. (Pubitemid 37336725)
4. Morrison RS, Wallensetin S, Natale DK, Senzel RS, Huang LL. "We don't carry that" - failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med. 2000;342:1023-1026.
5. Green CR, Ndao-Brumblay SK, West B, Washington T. Differences in prescription opioid analgesics availability: comparing minority and white pharmacies across Michigan. J Pain. 2005;6:689-699. (Pubitemid 41395061)
6. Foley KM. The treatment of pain in the patient with cancer. CA Cancer J Clin. 1986;36:194-215.
7. Carr DB, Goudas LC, Balk EM, Bloch R, Ioannidis JPA, Lau J. Evidence report on the treatment of pain in cancer patients. J Natl Cancer Inst Monogr. 2004;32:23-31.
8. Portenoy RK. Practical aspects of pain control in the patient with cancer. CA Cancer J Clin. 1988;38:327-352. (Pubitemid 19015990)
9. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592-596. (Pubitemid 24065792)
10. Fine PG, Miaskowski C, Paice JA. Meeting the challenges in cancer pain management. J Support Oncol. 2004;2(4):5-22. (Pubitemid 40100648)
11. Joranson DE, Gilson AM. Wanted: a public health approach to prescription opioid abuse and diversion (editorial). Pharmacoepidemiol Drug Saf. 2006;15:632-634.
12. Gilson AM, Maurer MA, Joranson DE. State medical board members' beliefs about pain, addiction, and diversion and abuse: a changing regulatory environment. J Pain. 2007;8;682-691.
13. Fishman SM. Responsible Opioid Prescribing - A Physician's Guide. Washington, DC: Waterford Life Sciences; 2007:5-12.
14. National Drug Intelligence Center. National Prescription Drug Threat Assessment 2009. Available at: http://www.usdoj.gov/ndic/pubs33/33775/index.htm. Published April 2009.
15. Food and Drug Administration. FDA: Risk evaluation and mitigation strategies for certain opioid drugs; Notice of public meeting. Federal Register. 2009;74:17967. Published April 20, 2009. Public docket established (2009-N-0143).
16. United States Food and Drug Administration. FDA adopts interim plan to avoid shortage of medically necessary opioid. Available at: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm149563.htm. Published April 9, 2009.
17. Cancer Facts and Figures 2009. Atlanta, GA: American Cancer Society; 2009.
18. McGuire DB. Occurrence of cancer pain. J Natl Cancer Inst Monogr. 2004;32:51-56.
19. Brescia FJ, Portenoy RK, Ryan M, Krasnoff L, Gray G. Pain, opioid use, and survival in hospitalized patients with advanced cancer. J Clin Oncol. 1992;10:149-155.
20. National Institutes of Health State of the Science Statement. Symptom management in cancer: pain, depression, and fatigue. Available at: http://consensus.nih.gov/2002/2002CancerPainDepressionFatiguesos022main.htm. Accessed June 3, 2009.
21. Montague L, Green CR. Cancer and breatkthrough pain's impact on a diverse population. Pain Med. 2009;10:549-561.
22. Sun V, Borneman T, Ferrell B, et al. Overcoming barriers to cancer pain management: an institutional change model. J Pain Symptom Manage. 2007;34:359-369. (Pubitemid 47454701)
23. Mangione M, Crowley-Matoka M. Improving pain management communication: how patients understand the terms "opioid" and "narcotic". J Gen Intern Med. 2008;23(9):1336-1338.
24. Management of Cancer Pain: Clinical Guideline Number 9. Rockville, Md: Agency for Health Care Policy and Research; 1994.
25. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management: a survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993;119:121-126. (Pubitemid 23286477)
26. Simone CB, Vapiwala N, Hampshire MK, Metz JM. Internetbased survey evaluating use of pain medications and attitudes of radiation oncology patients toward pain intervention. Int J Radiat Oncol Biol Phys. 2008;72:127-133
27. Joranson DE, Gilson MS. Controlled substances, medical practice, and the law. In: Schwartz HI, ed. Psychiatric Practice Under Fire: The Influence of Government, the Media and Special Interests on Somatic Therapies. Washington, DC: American Psychiatric Press; 1994:173-194.
28. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA. 2000;283:1710-1714.
29. Achieving Balance in State Pain Policy: A Progress Report Card (Fourth edition). Madison, Wis: University of Wisconsin Paul P. Carbone Comprehensive Cancer Center; 2008.
30. Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: a new frontier. Pain Med. 2007:8:189-198. (Pubitemid 46243373)